Search results
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 weeks agoIovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2024 Earnings Call Transcript May 9, 2024 Iovance...
Airspace closures, staff shortages and ageing tech: What’s behind 2023’s air traffic disruption?
Euronews via Yahoo News· 6 months agoWe all appreciate the pilots who fly us safely to our destination. Some of us even clap for them on...
Think You Know Your Climbing Terms? Take This Quiz and Find Out.
Outside via Yahoo News· 2 years agoThis article originally appeared on Climbing RPs, ATCs, PCDs … what on earth? At times, learning new...
Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
Zacks via Yahoo Finance· 4 weeks agoIovance (IOVA) reports mixed first-quarter results. Shares gain on encouraging initial demand for...
Iovance (IOVA) Up 5% on Updated Data From Melanoma Study
Zacks via Yahoo Finance· 2 weeks agoIovance (IOVA) shares updated data from a mid-stage study, which showed that treatment with its...
How Biden easing marijuana regulations would affect NH
Portsmouth Herald via Yahoo News· 1 month agoThe Biden administration plans to remove marijuana from a list of the most dangerous and highly...
3 Under-the-Radar Tech Stocks With 250% Growth Potential by 2026
InvestorPlace via Yahoo Finance· 5 months agoIn the tech space, certain tech stocks stand as front-liners of innovation and strategic brilliance....
City of Piqua to kick of second phase of Lock 9 Park project with groundbreaking
WHIO via Yahoo News· 12 months agoThe City of Piqua plans to break ground today on the next phase of a park project that’s been years...
FAA gets more than 57,000 applicants for air traffic control jobs
ABC News via Yahoo News· 2 years agoAs the Federal Aviation Administration (FAA) continues to deal with staffing issues on a nearly...
Q4 2023 Iovance Biotherapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 months agoParticipants Sara Pellegrino; Senior Vice President, Investor Relations and Corporate Communications; Iovance Biotherapeutics Inc Frederick Vogt; Interim President and Chief Executive Officer ...
